Related Experiment Video
Updated: Jan 17, 2026

03:14
Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
Published on: December 6, 2024
1.0K
Comparative Evaluation of Clinical Large Language Models and Machine Learning to Predict Antimicrobial Resistance in
Scott A Cohen1, Ziyi Chen2, Jiang Bian3
1Department of Epidemiology, University of Florida, Gainesville, FL, USA.
Summary
Large language models (LLMs) show promise in predicting antimicrobial resistance (AMR), specifically methicillin-resistant Staphylococcus aureus (MRSA), outperforming traditional machine learning models in hospital-onset sepsis prediction.
Area of Science:
- Medical Informatics
- Computational Biology
- Infectious Diseases
Background:
- Antimicrobial resistance (AMR) poses a significant threat, particularly in critically ill patients.
- Effective empiric antimicrobial therapy guidance is crucial for managing infections, especially with rising AMR rates.
- Predictive models for AMR are needed for clinical adoption, requiring scalability and generalizability.
Purpose of the Study:
- To compare the performance of a clinical large language model (LLM) against traditional machine learning (ML) for predicting AMR and methicillin-resistant Staphylococcus aureus (MRSA).
- To evaluate the utility of electronic health record (EHR) data at illness onset for early AMR and MRSA prediction in hospital-onset sepsis.
- To assess the potential of LLMs in guiding antimicrobial therapy in the context of prevalent AMR.
Main Methods:
- Utilized a publicly available clinical LLM (Gatortron) and traditional ML models.
- Analyzed EHR data from approximately 150,000 hospitalizations (2010-2023) at a large tertiary care system.
- Focused on a hospital-onset sepsis cohort (2,019 encounters) to predict AMR and MRSA presence.
Main Results:
- LLMs demonstrated superior performance in predicting MRSA compared to traditional ML models (AUC 0.73 vs. 0.66).
- LLMs achieved significantly higher F1 scores for MRSA prediction (0.43 vs. 0.16 for ML).
- The LLM achieved a negative predictive value of at least 90% for MRSA prediction across most infection types.
Conclusions:
- Clinical LLMs show significant potential for early prediction of AMR and MRSA using EHR data.
- LLMs offer a promising approach to guide empiric antimicrobial therapy, even with simplified feature sets.
- Further refinement of LLM-based prediction models is necessary to enhance sensitivity and clinical applicability for widespread adoption.